| Kristin E Lutz, | |
|
116 Defense Hwy Ste 400, Annapolis, MD 21401-7050 | |
| (410) 897-9841 | |
| (410) 897-9852 |
| Full Name | Kristin E Lutz |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 116 Defense Hwy Ste 400, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639826852 | NPI | - | NPPES |
| Entity Name | Annapolis Internal Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477629681 PECOS PAC ID: 2163324997 Enrollment ID: O20040122000965 |
News Archive
A Canadian study available on the preprint server medRxiv* shows that current smokers are slightly more likely than never smokers to test positive for coronavirus disease (COVID-19), but cautions about the possibility of reverse causality where smokers actually quit to avoid the disease.
The COVID-19 pandemic was predicted to and has had a major impact on the essential HIV health services in the South East Asia Region (SEAR), putting at risk the benefits accrued over the last two decades. Apart from the risks posed by the virus to the individual health of people living with HIV (PLHIV), COVID-19 has disrupted essential services causing considerable delays in the delivery of medicines and other health commodities.
ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).
medwireNews: Autoantibodies to endothelin receptor type A and angiotensin receptor type-1 predict the development of, and mortality from, systemic sclerosis-associated pulmonary arterial hypertension, research suggests.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment of the first patient in a Phase 2 study with CXA-201. This multicenter, double-blind, randomized, study will compare the safety and efficacy of intravenous CXA-201 with an active comparator in patients with complicated intra-abdominal Infections (cIAI). This international study is expected to enroll 120 patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin E Lutz, 429 Maple Leaf Dr, Edgewater, MD 21037-3207 Ph: (407) 432-7390 | Kristin E Lutz, 116 Defense Hwy Ste 400, Annapolis, MD 21401-7050 Ph: (410) 897-9841 |
News Archive
A Canadian study available on the preprint server medRxiv* shows that current smokers are slightly more likely than never smokers to test positive for coronavirus disease (COVID-19), but cautions about the possibility of reverse causality where smokers actually quit to avoid the disease.
The COVID-19 pandemic was predicted to and has had a major impact on the essential HIV health services in the South East Asia Region (SEAR), putting at risk the benefits accrued over the last two decades. Apart from the risks posed by the virus to the individual health of people living with HIV (PLHIV), COVID-19 has disrupted essential services causing considerable delays in the delivery of medicines and other health commodities.
ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).
medwireNews: Autoantibodies to endothelin receptor type A and angiotensin receptor type-1 predict the development of, and mortality from, systemic sclerosis-associated pulmonary arterial hypertension, research suggests.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment of the first patient in a Phase 2 study with CXA-201. This multicenter, double-blind, randomized, study will compare the safety and efficacy of intravenous CXA-201 with an active comparator in patients with complicated intra-abdominal Infections (cIAI). This international study is expected to enroll 120 patients.
› Verified 5 days ago
Brenda Kay Mathews-vitello, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 Defense Hwy, Suite 400, Annapolis, MD 21401 Phone: 410-897-9841 Fax: 410-897-9852 | |
Mrs. Jillian Lynn Preston, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 166 Defense Hwy Ste 101, Annapolis, MD 21401 Phone: 877-461-1564 | |
Alexa Lee St Laurent, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2024 West St Ste 400, Annapolis, MD 21401 Phone: 410-224-7667 Fax: 410-224-7007 | |
Dabney Lipscomb, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Wayson Pavilion, Suite 150, Annapolis, MD 21401 Phone: 443-481-1199 Fax: 443-481-1495 | |
Ms. Stephanie Zwonitzer, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1750 | |
Mrs. Hollis Stewart Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 678 Genessee St, Annapolis, MD 21401 Phone: 412-508-7896 | |
Lisa Kristine Butler, MSN, CRNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2002 Medical Pkwy Ste 670, Annapolis, MD 21401 Phone: 443-481-1150 |